about
Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in miceAnti-inflammatory and antifibrotic effects of a combination of spiperone and immobilized hyaluronidase on partially reversible and irreversible toxic pneumofibrosis.Antifibrotic effects of immobilized hyaluronidase in repeated bleomycin-induced lesions of the alveolar epithelium.Antifibrotic effect of combined treatment with neuroleptic drug and immobilized hyaluronidase in pulmonary fibrosis.Effect of granulocytic colony-stimulating factor on cytostatic-suppressed granulocytopoiesis under conditions of exhausted catecholamine depot.Potentiation of the stimulatory effect of erythropoietin on erythropoiesis by antiserotonin drug during cytostatic myelosuppression.Effect of Noolit, a novel lithium preparation, on electrophysiological activity of rat cerebral cortex.Adrenergic regulation of erythropoiesis during cytostatic-induced myelosuppressions.Role of central adrenergic structures in the regulation of granulocytopoiesis during cytostatic treatment.Reaction of bone marrow hematopoiesis to the toxic effect of paclitaxel.Dopaminergic regulation of granulocytopoiesis during cytostatic-induced myelosuppressions.Role of Thy 1,2+ cells in the regulation of hemopoiesis during experimental neuroses.Role of serotonin in the regulation of granulocytopoiesis during cytostatic-induced myelosuppressions.Response of Inflammatory Mediators, Extracellular Matrix Proteins and Stem and Progenitor Cells to Emphysema.Possible mechanisms underlying the effect of natural preparations on erythropoiesis under conditions of conflict situation.Individual and typological behavioral characteristics of CBA/CaLac mice.Monoaminergic regulation of proliferation and differentiation of granulomonocytopoietic precursors during neuroses.Monoaminergic regulation of the pool of erythropoietic stem cells in active and passive mouse in experimental neuroses.Parmacological regulation of erythropoietic precursor pool in experimental neuroses.Role of Sertoli and Leydig Cells in the Regulation of Spermatogonial Stem Cell and Development of Reproductive Disorders in Male C57Bl/6 Mice with Type 1 Diabetes Mellitus.Effects of Pegylated Glucagon-Like Peptide-1 Analogue in C57Bl/6 Mice under Optimal Conditions and During Streptozotocin-Induced Diabetes.Role of Tissue-Specific Stem and Progenitor Cells in the Regeneration of the Pancreas and Testicular Tissue in Diabetic Disorders.Response of Stem and Progenitor Cells to Testicular Ischemia.Response of hemopoietic, progenitor, and multipotent mesenchymal stromal cells to administration of ketanserin during pulmonary fibrosis.Differentiation of mesenchymal multipotent stromal cells of the lungs in pneumofibrosis.Response of Hematopoietic Stem and Progenitor Cells to Reserpine in C57Bl/6 Mice.Hemostimualting properties of preparation containing ultralow doses of antibodies to stem cell factor in cytostatic myelosuppression.Regenerative Potential of Spermatogonial Stem Cells, Endothelial Progenitor Cells, and Epithelial Progenitor Cells of C57Bl/6 Male Mice with Metabolic Disorders.Endothelial Progenitor Cells as Pathogenetic and Diagnostic Factors, and Potential Targets for GLP-1 in Combination with Metabolic Syndrome and Chronic Obstructive Pulmonary DiseaseParticipation of mesenchymal precursor cells in wound healing on skin flap modelRole of hemopoietic precursors of various classes in the effect of granulocyte colony-stimulating factor on hemopoiesis during cytostatic-induced myelosuppressionRole of stromal and Thy 1,2+ cells in the mechanisms of action of immobilized granulocyte colony-stimulating factor during cytostatic-induced myelosuppressionHemopoiesis-stimulating activity of immobilized oligonucleotides and hyaluronidase during cytostatic-induced myelosuppressionEffect of immobilized granulocyte colony-stimulating factor on hemopoietic precursors of various classes during cytostatic-induced myelosuppressionEffects and mechanisms of hemopoiesis-stimulating activity of immobilized oligonucleotides under conditions of cytostatic myelosuppressionEffect of antiserotonin drug on the development of lung fibrosis and blood system reactions after intratracheal administration of bleomycinAntifibrotic and anti-inflammatory activity of a neuroleptic drug on the model of pulmonary fibrosisCatecholamine regulation of stromal precursors and hemopoietic stem cells in cytostatic myelosuppressionReactions of the blood system and stem cells in bleomycin-induced model of lung fibrosisMechanisms of the anti-inflammatory and antifibrotic activity of a sympatholytic agent during toxic pulmonary fibrosis
P50
Q27308781-D4D83547-D6AC-4104-B074-B2C22BD732FAQ39298800-64448915-B464-4C7E-AA15-2DE37ADB2E81Q39329326-F9A49B39-FAAF-401C-8DB5-43583B520B3CQ39452865-0AA4F0A5-410B-4918-99DE-F2F4DA7F1908Q43243929-8DC92A70-255E-46AF-9D86-24BB435AA3B8Q43245223-A56558E1-3255-45FB-A0CB-B5D343643F80Q44992800-AAF9CF91-1B60-4F82-A0C8-0B66D03D36B2Q45986384-AEECCD4B-DF31-4EC2-B67E-C9C15B2493CCQ46182151-B1BE045B-A2D9-4890-9095-778F05E8094BQ46234804-DB70229D-E9E8-4909-92AF-88C738FA11C9Q46611691-CEA7079C-D9D7-4F67-990F-CA805B00131AQ46752538-415F022C-32BA-407A-BB44-4B505225C48BQ46779168-43E533AB-68CE-4F22-990D-F613626F0452Q48009723-3BD224EC-7E21-4660-A111-CD8FC24185EBQ48137949-0970C9F4-EEC8-457D-BF94-E23583A1F692Q48349840-0BE7451D-3C8B-4189-BEAB-1AF44E8572A0Q48409598-2BFE622F-0F6A-4768-A4FF-DA82971ACE46Q48498051-E2C89118-60A5-41DB-9323-F6B1E5D22C13Q48498060-A00CF1C0-85B6-4FBD-A59D-9629E4F3CAD8Q49580656-556A6BE7-1458-4A22-A077-99B336506E3DQ49834271-C6367558-BE6E-4F69-B2F2-273390A825E9Q51308861-49AF6529-BE1F-4463-8C95-CB7DD9D252BBQ51535057-88AECE50-1E24-4C70-9FCE-130C9DC686C5Q53003638-67516E47-CFD4-469C-B581-470B766D8DF8Q53116582-0FA6F4F7-D94B-4268-8DB5-DC354189DCA2Q53168109-03A074D8-5947-41BF-9D41-8FDCF8BB7345Q53329327-A1856E2D-3DF7-493F-BC8B-C7518118422AQ54997386-5380BD08-0164-43E4-94D4-FF9F49E5094EQ64068217-229FFD0A-ED1C-4678-91AB-30A6415E8681Q79977115-1DDB36D6-FCBB-4628-ACA7-976248B2F661Q83203849-86DF6E18-9688-44CC-B9CF-F4772115B8DBQ83208502-15AE34C8-6545-4664-8BF4-650999AAF834Q83208521-B41E90C7-A58B-4E04-A26B-231D24E4DCD9Q83233193-195445DA-7E19-47A9-9E23-8BE7B043DB1CQ84579410-33A08395-DA7A-41C7-A0D8-8BBB77F932D2Q84579424-A009CCAE-6FD3-439E-B509-8D07333283AAQ84579476-96022D19-4818-4D08-B807-24AC224625C1Q84579484-3562C249-4BD0-4C41-9E92-368C48A95849Q84584461-047F7956-193A-4F48-8246-5A6FDC5A7610Q85322808-5F063E12-AD46-4C00-B0F5-BB71DAB8711D
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-0468-0272
@en
name
Olga Pershina
@en
Olga Victorovna Pershina
@ast
Olga Victorovna Pershina
@es
Olga Victorovna Pershina
@nl
Olga Wiktorowna Perschina
@de
Ольга Викторовна Першина
@ru
type
label
Olga Pershina
@en
Olga Victorovna Pershina
@ast
Olga Victorovna Pershina
@es
Olga Victorovna Pershina
@nl
Olga Wiktorowna Perschina
@de
Ольга Викторовна Першина
@ru
altLabel
Olga Perschina
@de
Olga Victorovna Pershina
@en
Olga Viktorovna Pershina
@en
prefLabel
Olga Pershina
@en
Olga Victorovna Pershina
@ast
Olga Victorovna Pershina
@es
Olga Victorovna Pershina
@nl
Olga Wiktorowna Perschina
@de
Ольга Викторовна Першина
@ru
P106
P1153
6507476814
P21
P31
P496
0000-0002-0468-0272